Back to search results

SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)

Abroad (travel likely)RecruitingPHASE2

Conditions

Endometrial Cancer Stage I · Mmr Deficiency · Endometrioid Endometrial Adenocarcinoma · Immune-related Adverse Event

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Westmead Hospital, Sydney, New South Wales, Australia

    Contact: Study coordinator (Sara Baniahmadi) · s.baniahmadi@uq.edu.au · 07 3346 5073
    Contact: Principal Investigator (Alison Brand, Professor)

  • Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia

    Contact: Study coordinator (Sara Baniahmadi) · s.baniahmadi@uq.edu.au · 07 3346 5073
    Contact: Study coordinator (Brianna armstrong) · bri.armstrong@uq.edu.au · 07 3346 5063
    Contact: Principal Investigator (Jeffrey Goh, Associate Professor)

  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

    Contact: Study coordinator (Sara Baniahmadi) · s.baniahmadi@uq.edu.au · 07 3346 5073
    Contact: Principal Investigator (Linda Mileshkin, Professor)
    Orla McNally, A/Professor (Sub-investigator)
Study leads

  • Andreas Obermair, Professor

    Study Chair

    Queensland Centre for Gynaecological Cancer (QCGC) Research

View source on ClinicalTrials.gov(opens in a new tab)